Du surfar just nu på en begränsad version av umu.se. Vad innebär det här?

"False"
Umeå universitet
printicon
Huvudmenyn dold.
Personalbild Björn Pilebro

Björn Pilebro

Kontakt

E-post
bjorn.pilebro@umu.se
Telefon
090-786 90 20

Verksam som

Anknytning
Biträdande universitetslektor, kombinerad med klinisk tjänstgöring vid Institutionen för folkhälsa och klinisk medicin Enhet: Kardiologi
Plats
1A, 4tr. Målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå
Nexiguran ziclumeran gene editing in hereditary ATTR with polyneuropathy
New England Journal of Medicine, Massachusetts Medical Society 2025, Vol. 393, (14) : 1375-1386
Gillmore, Julian D.; Gane, Ed; Täubel, Jörg; et al.
Sixty years of experience with hereditary transthyretin amyloidosis: insights from the Swedish transthyretin amyloidosis registry
Journal of Internal Medicine, John Wiley & Sons 2025, Vol. 298 : 478-488
Stenberg, Lotta; Pilebro, Björn; Anan, Intissar; et al.
Introducing a revised version of the Kumamoto scale as an easy-to-use clinical tool for monitoring multisystemic changes in hereditary transthyretin amyloidosis
Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2025, Vol. 20, (1)
Wixner, Jonas; Pilebro, Björn; Wien, Tale N.; et al.
Assessing left atrial dysfunction in cardiac amyloidosis using LA-LV strain slope
European Heart Journal - Imaging Methods and Practice, Oxford University Press 2024, Vol. 2, (3)
Edbom, Fredrik; Lindqvist, Per; Wiklund, Urban; et al.
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
New England Journal of Medicine, Massachussetts Medical Society 2024, Vol. 391, (23) : 2231-2241
Fontana, Marianna; Solomon, Scott D.; Kachadourian, Jessica; et al.
Echocardiographic red flags of ATTR cardiomyopathy a single centre validation
European Heart Journal. Imaging Methods and Practice, Oxford University Press 2024, Vol. 2, (3)
Henein, Michael Y.; Pilebro, Björn; Lindqvist, Per
Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis
Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2024, Vol. 31, (4) : 342-343
Pilebro, Björn; Wixner, Jonas; Anan, Intissar
Association of right ventricular myocardial blood flow with pulmonary pressures and outcome in cardiac amyloidosis
JACC Cardiovascular Imaging, Elsevier 2023, Vol. 16, (9) : 1193-1204
Harms, Hendrik J.; Clemmensen, Tor; Rosengren, Sara; et al.
Amyloid fibril composition type is consistent over time in patients with Val30Met (p. Val50Met) transthyretin amyloidosis
PLOS ONE, Public Library of Science 2022, Vol. 17, (3)
Anan, Intissar; Suhr, Ole B.; Liszewska, Katarzyna; et al.
RWT/SaVR-A Simple and Highly Accurate Measure Screening for Transthyretin Cardiac Amyloidosis
Journal of Clinical Medicine, MDPI 2022, Vol. 11, (14)
Arnberg, Elsa; Eldhagen, Per; Löfbacka, Viktor; et al.
Disease progression in cardiac morphology and function in heart failure: ATTR cardiac amyloidosis versus hypertensive left ventricular hypertrophy
Heart and Vessels, Springer 2022, Vol. 37 : 1562-1569
Henein, Michael Y.; Pilebro, Björn; Lindqvist, Per
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation
American Journal of Transplantation, John Wiley & Sons 2022, Vol. 22, (6) : 1646-1657
Schmidt, Hartmut H.; Wixner, Jonas; Planté-Bordeneuve, Violaine; et al.
Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors
Frontiers in Neurology, Frontiers Media S.A. 2022, Vol. 13
Unéus, Erica Irene; Wilhelmsson, Christer; Bäckström, David; et al.
Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic
ESC Heart Failure, John Wiley & Sons 2021, Vol. 8, (1) : 745-749
Lindmark, Krister; Pilebro, Björn; Sundström, Torbjörn; et al.
Cardiac transthyretin amyloidosis 99mTc-DPD SPECTcorrelates with strain echocardiography and biomarkers
European Journal of Nuclear Medicine and Molecular Imaging, Springer 2021, Vol. 48 : 1822-1832
Löfbacka, Viktor; Axelsson, Jan; Pilebro, Björn; et al.
Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure
Clinical Physiology and Functional Imaging, John Wiley & Sons 2021, Vol. 41, (5) : 408-416
Löfbacka, Viktor; Suhr, Ole B.; Pilebro, Björn; et al.
Quantification of cardiac amyloid with [18F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis
Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2020, Vol. 27, (3) : 191-199
Möckelind, Sofia; Axelsson, Jan; Pilebro, Björn; et al.
Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis
Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2020, Vol. 15, (1)
Paulsson Rokke, Hedvig; Sadat Gousheh, Nima; Westermark, Per; et al.
Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type
Scandinavian Journal of Clinical and Laboratory Investigation, Taylor & Francis 2019, Vol. 79, (6) : 372-376
Hellman, Urban; Lång, Kenneth; Ihse, Elisabet; et al.
Prevalence of transthyretin cardiac amyloidosis in a community-based heart failure population
European Heart Journal, Oxford University Press 2019, Vol. 40 : 132-132
Lindmark, Krister; Pilebro, Björn; Solekrans, L.; et al.
Visualisation of amyloid deposition within the brain of long-term hereditary transthyretin amyloidosis survivors by 18F-flutemetamol positron emission tomography
European Journal of Neurology, John Wiley & Sons 2019, Vol. 26, (S1) : 287-287
Unéus, Erica; Wilhelmsson, Christer; Suhr, Ole; et al.
The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition
Amyloid: Journal of Protein Folding Disorders, Taylor & Francis Group 2019, Vol. 26 : 39-40
Wixner, Jonas; Westermark, Per; Ihse, Elisabet; et al.
Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis
Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2018, Vol. 25, (1) : 46-53
Henein, Michael Y.; Suhr, Ole B.; Arvidsson, Sandra; et al.
Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)
Journal of Nuclear Cardiology, Springer 2018, Vol. 25, (1) : 240-248
Pilebro, Björn; Arvidsson, Sandra; Lindqvist, Per; et al.
Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients
Transplantation, LIPPINCOTT WILLIAMS & WILKINS 2018, Vol. 102, (2) : e59-e66
Wange, Niklas; Anan, Intissar; Ericzon, Bo-Göran; et al.
The heart in hereditary transthyretin amyloidosis: clinical studies on the impact of amyloid fibril composition
Umeå University medical dissertations, 1904
Pilebro, Björn
The Swedish landscape of hereditary ATTR amyloidosis
Amyloid: Journal of Protein Folding Disorders, Vol. 24, (1) : 93-94
Suhr, Ole B; Wixner, Jonas; Pilebro, Björn; et al.
Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis
Amyloid: Journal of Protein Folding Disorders, Vol. 24, (1) : 78-79
Wixner, Jonas; Pilebro, Bjorn; Lundgren, Hans-Erik; et al.
Long mitral valve leaflets determine left ventricular outflow tract obstruction during exercise in hypertrophic cardiomyopathy
International Journal of Cardiology, Elsevier 2016, Vol. 212 : 47-53
Henein, Michael; Arvidsson, Sandra; Pilebro, Björn; et al.
99mTC-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
Upsala Journal of Medical Sciences, Taylor & Francis 2016, Vol. 121, (1) : 17-24
Pilebro, Björn; Suhr, Ole B.; Näslund, Ulf; et al.
Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition
PLOS ONE, Vol. 10, (11)
Arvidsson, Sandra; Pilebro, Björn; Westermark, Per; et al.
Gender related differences in cardiac function in patients with hereditary transthyretin amyloidosis
European Journal of Heart Failure, Vol. 17 : 64-65
Gustavsson, Sandra; Pilebro, Björn; Westermark, P.; et al.
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: a n-of-1 trial series pilot study
Håkansson, Erik; Anan, Intissar; Brunström, Mattias; et al.
Design and rationale of the ULRICA trial: using dapagliflozin to reduce symptoms and improve walking distance in transthyretin cardiac amyloidosis
Håkansson, Erik; Pilebro, Björn; Lindmark, Krister
Electrocardiographic features of hereditary V30M transthyretin amyloidosis, different phenotypes with similar findings
Pilebro, Björn; Suhr, Ole B; Ihse, Elisabeth; et al.
Visa publikationer i DiVA
Björn Pilebro: Genredigering – lovande behandling mot Skelleftesjukan

Björn Pilebro om den första genterapistudie på människa som forskare vid Umeå universitet är delaktiga i.